In the present study we showed by molecular analysis that the inhibition of motility by macrolides in Proteus mirabilis and Pseudomonas aeruginosa was well correlated with the loss of the expression of flagellin. Erythromycin, clarithromycin, and azithromycin at subinhibitory concentrations (sub-MICs) suppressed the expression of flagellin dose dependently. Azithromycin had the strongest inhibitory effect on the expression of P. aeruginosa flagellin, whereas 16-membered rokitamycin had only a weak inhibitory effect. These results indicate the potential effectiveness of sub-MICs of erythromycin, clarithromycin, and azithromycin for the treatment of patients with P. mirabilis and P. aeruginosa infections.Macrolide antibiotics have been widely used to treat various infections. They bind to the 50S ribosomal subunit, resulting in blockage of transpeptidation and/or translocation. The antimicrobial activity of macrolides is broad in spectrum, being exhibited against gram-positive and some gram-negative bacteria, such as Neisseria spp., Campylobacter spp., Haemophilus spp., and Legionella spp. (4). In contrast, most species of Enterobacteriaceae and nonglucose-fermenting gram-negative rods such as Pseudomonas spp. are innately resistant to macrolides (15).Some reports have demonstrated that the treatment of bacteria with subinhibitory concentrations (sub-MICs) of macrolide antibiotics suppressed the expression of bacterial virulence factors in various gram-negative rods (5, 8). Although Pseudomonas aeruginosa is generally highly resistant to macrolides, erythromycin (ERY) suppressed the production of exotoxin A and proteases by this organism at concentrations well below the MIC (6). It was also demonstrated that sub-MICs of macrolide antibiotics decreased protein synthesis (18), enhanced the sensitivity of P. aeruginosa in serum (17), and suppressed biofilm formation through inhibition of alginic acid (7). Based on these reports, certain macrolides at sub-MICs were expected to have clinical effects on patients with respiratory infections caused by gram-negative rods such as P. aeruginosa, and in fact long-term low-dose administration of ERY produced clinical improvement in patients with diffuse pulmonary panbronchiolitis associated with P. aeruginosa infection (16).The present study was therefore undertaken to clarify the in vitro effectiveness of sub-MICs of macrolides as assessed by the inhibition of flagellin expression in P. aeruginosa and Proteus mirabilis. Flagella are among the virulence factors of gramnegative rods and have a role in the initiation of biofilm formation (14). Early studies showed that exposure to sub-MICs of the macrolide azithromycin (AZM) resulted in loss of motility due to the absence of flagella in P. mirabilis and P. aeruginosa (10, 11). However, these observations were based on the conventional light-microscopic examinations and therefore were not quantitative. We describe here the results of molecular analysis of the flagellin inhibition by sub-MICs of macrolides.Nonmucoid P. aeruginosa ...
Since several Acinetobacter clinical isolates have developed augmented resistance to multiple antimicrobials and disinfectants, it is worth checking the susceptibility to disinfectants if multidrug-resistant Acinetobacter spp. are recurrently isolated clinically.
Given that the bactericidal effects of the four major disinfectants were considerably reduced in the presence of organic material (BSA) and DRS isolates tended to adapt to CHX, continuous surveys of the profiles of susceptibility to disinfectants among clinically isolated Acinetobacter species are very necessary from the standpoint of nosocomial infection control.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.